Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model (Q41263250)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1995

Language	Label	Description	Also known as
English	Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model	scientific article published on December 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model (English)

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

prostate carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Soff GA

1

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Sanderowitz J

2

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Gately S

3

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Verrusio E

4

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Weiss I

5

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Brem S

6

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Kwaan HC

7

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

language of work or name

0 references

publication date

1 December 1995

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

96

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

6

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

2593-2600

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Construction of plasmids that express E. coli beta-galactosidase in mammalian cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Plasminogen activation and regulation of pericellular proteolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

The role of urokinase-type plasminogen activator in aggressive tumor cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Components of the Plasminogen-Plasmin System in Human Tumor Cell Lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

The plasminogen activator/plasmin system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

The plasminogen-plasmin system in malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

A study of proteases and protease-inhibitor complexes in biological fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

1 October 2017

Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Laminin immunohistochemistry: a simple method to visualize and quantitate vascular structures in the mammalian brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Amiloride selectively inhibits the urokinase-type plasminogen activator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

14 June 2018

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

19 August 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

19 August 2018

Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185963

19 August 2018

Factors involved in the plasminogen activation system in human breast tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Content and characterization of plasminogen activators in human lung tumors and normal lung tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved medium for extraction of plasminogen activator from tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ouabain resistance conferred by expression of the cDNA for a murine Na+, K+-ATPase alpha subunit

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimetastatic effect of amiloride in an animal tumour model

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neovascularization in kainic acid-induced lesions of rat striatum. An immunohistochemical study with laminin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8675623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI118323

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41263250&oldid=2095743727"